EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan

Motoko Yamaguchi, Noriko Fukuhara, Jun Takizawa, Kenji Ishitsuka, Akihiko Yokohama, Kana Miyazaki, Yuma Nato, Satoshi Ichikawa, Masaki Mitobe, Kodai Shima, Yuri Miyazawa, Koji Izutsu und 3 weitere

Journal of Clinical and Experimental Hematopathology · 2024

DOI: 10.3960/jslrt.24028 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2024. Verfasst von Motoko Yamaguchi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan. Hauptthemen laut MEDLINE: Alemtuzumab, Leukemia, Prolymphocytic, T-Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlemtuzumabLeukemia, Prolymphocytic, T-CellHumansAgedMiddle AgedMaleFemaleJapanAdultRetrospective StudiesTreatment OutcomeAntineoplastic Agents, Immunological

Stichwörter der Autor:innen

JapaneseT-cell prolymphocytic leukemiaalemtuzumabmonotherapy

Substanzen

AlemtuzumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan.
  • Department of Hematology, Tohoku University Hospital, Sendai, Japan.
  • Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan.
  • Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.

Zitieren

APA

Yamaguchi, M., Fukuhara, N., Takizawa, J., Ishitsuka, K., Yokohama, A., Miyazaki, K., Nato, Y., Ichikawa, S., Mitobe, M., Shima, K., Miyazawa, Y., Izutsu, K., Suzuki, R., Nagai, H., & Nakamura, N. (2024). Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.24028

Vancouver

Yamaguchi M, Fukuhara N, Takizawa J, Ishitsuka K, Yokohama A, Miyazaki K, et al. Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan. Journal of Clinical and Experimental Hematopathology. 2024. doi:10.3960/jslrt.24028

BibTeX
@article{Yamaguchi2024,
  author = {Yamaguchi, Motoko and Fukuhara, Noriko and Takizawa, Jun and Ishitsuka, Kenji and Yokohama, Akihiko and Miyazaki, Kana and Nato, Yuma and Ichikawa, Satoshi and Mitobe, Masaki and Shima, Kodai and Miyazawa, Yuri and Izutsu, Koji and Suzuki, Ritsuro and Nagai, Hirokazu and Nakamura, Naoya},
  title = {Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2024},
  doi = {10.3960/jslrt.24028}
}
Kostenlos starten →